SUPERNUS PHARMACEUTICALS, INC. - COM (SUPN)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
55.7 M
Holdings value Q1 2024
$1.9 B
Value change Q1 2024
-$17.1 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
236
Number of buys Q1 2024
94
Number of sells Q1 2024
-124
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
868459108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 55.7 M $1.9 B -$17.1 M $34.11 236
2023 Q4 56.3 M $1.63 B -$2.92 M $28.94 239
2023 Q3 56.6 M $1.56 B -$16.8 M $27.57 232
2023 Q2 56.8 M $1.71 B +$26 M $30.06 240
2023 Q1 55.2 M $2 B -$15.7 M $36.23 251
2022 Q4 55.8 M $1.99 B +$9.2 M $35.67 257
2022 Q3 53.2 M $1.8 B +$13.8 M $33.85 231
2022 Q2 54.1 M $1.57 B +$43.4 M $28.92 209
2022 Q1 53.5 M $1.73 B -$41.2 M $32.32 220
2021 Q4 54.6 M $1.59 B +$20.5 M $29.16 223
2021 Q3 54.3 M $1.45 B +$2.48 M $26.67 215
2021 Q2 53.9 M $1.66 B +$28.5 M $30.79 221
2021 Q1 53.1 M $1.39 B +$12.2 M $26.18 215
2020 Q4 52.8 M $1.33 B +$29.3 M $25.16 217
2020 Q3 50.4 M $1.05 B +$16 M $20.84 199
2020 Q2 50.2 M $1.19 B +$47.1 M $23.75 211
2020 Q1 47.3 M $852 M -$50.7 M $17.99 191
2019 Q4 50.4 M $1.2 B +$9.11 M $23.72 224
2019 Q3 50.2 M $1.38 B -$77.5 M $27.48 232
2019 Q2 51.5 M $1.7 B +$15.9 M $33.09 258
2019 Q1 52.9 M $1.85 B +$40 M $35.04 273
2018 Q4 51.2 M $1.7 B -$14.3 M $33.22 257
2018 Q3 51.5 M $2.59 B -$111 M $50.35 278
2018 Q2 53.3 M $3.19 B +$187 M $59.85 312
2018 Q1 51.2 M $2.34 B +$81.6 M $45.80 305
2017 Q4 49.6 M $1.98 B -$48.6 M $39.85 287
2017 Q3 50.8 M $2.03 B +$95.4 M $40.00 271
2017 Q2 46.9 M $2.02 B +$105 M $43.10 261
2017 Q1 46 M $1.44 B +$218 M $31.30 241
2016 Q4 45.3 M $1.14 B -$18.5 M $25.25 226
2016 Q3 46 M $1.13 B -$8.99 M $24.73 215
2016 Q2 46 M $938 M +$63.3 M $20.37 208
2016 Q1 44.6 M $680 M +$7.46 M $15.25 205
2015 Q4 44.6 M $600 M -$43.2 M $13.44 201
2015 Q3 46.8 M $657 M +$61.8 M $14.03 179
2015 Q2 42.1 M $715 M +$79.1 M $16.98 163
2015 Q1 40.4 M $488 M +$45 M $12.09 117
2014 Q4 37 M $307 M +$10.7 M $8.30 104
2014 Q3 35.5 M $308 M -$18 M $8.69 92
2014 Q2 37 M $404 M +$41.9 M $10.95 86
2014 Q1 33.3 M $298 M +$21.6 M $8.94 81